PDS Biotechnology Corp SEC filings PDSB
PDS Biotechnology Corp has 795 filings in SEC EDGAR's recent list, going back to Sep 16, 2009. Its latest annual report, Form ARS, was filed on Jun 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 14, 2026 | — |
| 424B4 | Prospectus | Jul 21, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2026 | — |
| 424B5 | Prospectus supplement | Jun 15, 2026 | — |
| S-3/A | Filing | Apr 24, 2026 | — |
| S-8 | Employee stock plan registration | Dec 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2025 | — |
| S-3 | Shelf registration | May 27, 2025 | — |
| 424B5 | Prospectus supplement | Feb 28, 2025 | — |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-8 | Employee stock plan registration | Nov 14, 2023 | — |
| S-8 | Employee stock plan registration | Aug 24, 2022 | — |
| S-3 | Shelf registration | Aug 24, 2022 | — |
| S-8 | Employee stock plan registration | Apr 1, 2022 | — |
| S-8 | Employee stock plan registration | Nov 15, 2021 | — |
| 424B5 | Prospectus supplement | Jun 16, 2021 | — |
| 424B5 | Prospectus supplement | Jun 14, 2021 | — |
| 424B2 | Prospectus | Aug 12, 2020 | — |
| 424B5 | Prospectus supplement | Aug 10, 2020 | — |
| S-3 | Shelf registration | Jul 22, 2020 | — |
| 424B4 | Prospectus | Feb 12, 2020 | — |
| FWP | Free writing prospectus | Feb 11, 2020 | — |
| S-1/A | Amended registration statement | Jan 31, 2020 | — |
| FWP | Free writing prospectus | Jan 17, 2020 | — |
| S-1/A | Amended registration statement | Jan 17, 2020 | — |
| S-1 | Registration statement | Dec 17, 2019 | — |
| S-8 | Employee stock plan registration | Nov 14, 2019 | — |
| 424B3 | Prospectus | Aug 29, 2019 | — |
| S-1/A | Amended registration statement | Aug 20, 2019 | — |
| S-1 | Registration statement | Aug 2, 2019 | — |
| S-8 | Employee stock plan registration | Jun 4, 2019 | — |
| S-8 | Employee stock plan registration | Jun 4, 2019 | — |
| S-8 | Employee stock plan registration | Feb 22, 2019 | — |
| 424B3 | Prospectus | Feb 15, 2019 | — |
| S-4/A | Filing | Jan 25, 2019 | — |
| S-4 | Registration for a merger or exchange | Dec 21, 2018 | — |
| S-8 | Employee stock plan registration | Mar 2, 2018 | — |
| S-8 | Employee stock plan registration | Mar 2, 2018 | — |
| 424B5 | Prospectus supplement | Apr 19, 2017 | — |
| S-8 | Employee stock plan registration | Mar 3, 2017 | — |
| S-8 | Employee stock plan registration | Mar 3, 2017 | — |
| 424B2 | Prospectus | Nov 2, 2016 | — |
| S-3 | Shelf registration | Oct 21, 2016 | — |
| S-8 | Employee stock plan registration | Mar 9, 2016 | — |
| S-8 | Employee stock plan registration | Mar 9, 2016 | — |
| S-8 | Employee stock plan registration | Oct 21, 2015 | — |
| 424B4 | Prospectus | Oct 2, 2015 | — |
| S-1MEF | Form s-1mef | Sep 30, 2015 | — |
| S-1/A | Amended registration statement | Sep 21, 2015 | — |
| S-1 | Registration statement | Aug 14, 2015 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PDSB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1472091
- Former names
- Edge Therapeutics, Inc. (until Mar 18, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.